PMC:7172841 / 19438-19593 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T187","span":{"begin":63,"end":71},"obj":"Disease"},{"id":"T188","span":{"begin":63,"end":67},"obj":"Disease"},{"id":"T189","span":{"begin":151,"end":154},"obj":"Disease"}],"attributes":[{"id":"A187","pred":"mondo_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A188","pred":"mondo_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A189","pred":"mondo_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T181","span":{"begin":107,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89","span":{"begin":18,"end":20},"obj":"Chemical"}],"attributes":[{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A90","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}

{"project":"LitCovid-sentences","denotations":[{"id":"T149","span":{"begin":0,"end":155},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T540","span":{"begin":18,"end":22},"obj":"PR:000001393"},{"id":"T541","span":{"begin":63,"end":73},"obj":"SP_7"},{"id":"T542","span":{"begin":100,"end":106},"obj":"UBERON:0002405;GO:0006955"},{"id":"T543","span":{"begin":107,"end":117},"obj":"GO:0006955"},{"id":"T544","span":{"begin":133,"end":146},"obj":"GO:0065007"},{"id":"T25610","span":{"begin":7,"end":11},"obj":"PR:000001393"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}

{"project":"LitCovid-PubTator","denotations":[{"id":"719","span":{"begin":18,"end":22},"obj":"Gene"},{"id":"720","span":{"begin":35,"end":43},"obj":"Species"},{"id":"721","span":{"begin":63,"end":73},"obj":"Species"}],"attributes":[{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"Gene:3569"},{"id":"A720","pred":"tao:has_database_id","subj":"720","obj":"Tax:9606"},{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(H) Production of IL-6 by PBMCs of patients with CAP caused by SARS-CoV-2 classified into states of immune activation: intermediate, dysregulation and MAS."}